1. At a Glance – Minty Fresh, Balance Sheet Stronger Than Your Dentist’s Grip
Colgate-Palmolive (India) Ltd is that rare FMCG beast which doesn’t scream growth but quietly prints ₹1,333 Cr PAT (TTM) while brushing aside competition with ~51% toothpaste market share. Market cap sits at ₹57,485 Cr, stock price at ₹2,113, and returns over the last year are a painful -22.7%—because even kings get slapped when growth snoozes.
Yet look under the sink: ROCE at 105%, ROE at 81%, OPM ~31%, debt of just ₹60 Cr, and interest coverage that’s basically infinite (443x). Q3 FY26 numbers? Sales ₹1,486 Cr, PAT ₹324 Cr, EPS ₹11.91—steady, boring, dependable.
Advertising burns ~13% of revenue, distribution touches 1.6+ million stores, and promoters still own 51% with zero pledge. This is not a momentum stock; this is a toothpaste monopoly disguised as a boring uncle. Question is: are you okay with boredom if it pays dividends?
2. Introduction – The FMCG That Refuses to Die (Or Grow Fast)
Colgate is not trying to reinvent capitalism. It is trying to make sure every Indian brushes twice a day—preferably with Colgate Strong Teeth. Since the 1990s, it has defended leadership like a fort guarded by dentists, distributors, and daily habits that are harder to change than Indian parents’ opinions.
But markets are moody teenagers. When sales growth slows to ~6% CAGR, they sulk. When TTM profit growth turns -9%, they throw tantrums. Hence the stock correction.
Operationally though? This company is a cash geyser. Negative working capital, ridiculous margins, and a dividend payout that sometimes crosses 100%. The parent,
